Adelaide Research & Scholarship: Search

Search

Results 21-30 of 36 (Search time: 0.002 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2010	High-density mapping of the sinus node in humans: Role of preferential pathways and the effect of remodeling	Stiles, M.; Brooks, A.; Roberts-Thomson, K.; Kuklik, P.; John, B.; Young, G.; Kalman, J.; Sanders, P.
	2010	Comparing self-reported and measured high blood pressure and high cholesterol status using data from a large representative cohort study	Taylor, A.; DalGrande, E.; Gill, T.; Pickering, S.; Grant, J.; Adams, R.; Phillips, P.
	2010	Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond study	Dent, J.; Vakil, N.; Jones, R.; Bytzer, P.; Schnoning, U.; Halling, K.; Junghard, O.; Lind, T.
	2010	Prevalence and correlates of shoulder pain and stiffness in a population-based study: the North West Adelaide Health Study	Hill, C.; Gill, T.; Shanahan, E.; Taylor, A.
	2010	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)	Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
	2010	Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer	Peeters, M.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; Tzekova, V.; Collins, S.; Oliner, K.; Rong, A.; Gansert, J.
	2010	Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX study	Tebbutt, N.; Wilson, K.; Gebski, V.; Cummins, M.; Zannino, D.; van Hazel, G.; Robinson, B.; Broad, A.; Ganju, V.; Ackland, S.; Forgeson, G.; Cunningham, D.; Saunders, M.; Stockler, M.; Chua, Y.; Zalcberg, J.; Simes, R.; Price, T.
	2010	Challenging the holy grail of hospital accreditation: A cross sectional study of inpatient satisfaction in the field of cardiology	Sack, C.; Lutkes, P.; Gunther, W.; Erbel, R.; Jockel, K.; Holtmann, G.
	2010	Baseline factors predictive of serious suicidality at follow-up: findings focussing on age and gender from a community-based study	Fairweather-Schmidt, A.; Anstey, K.; Salim, A.; Rodgers, B.
	2010	Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study	Cortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.